[Operative treatment of secondary hyperparathyroidism in patients with terminal chronic renal insufficiency in programmed hemodialysis].
The phosphorous-calcic metabolism disorders and secondary hyperparathyroidism (HPTH) occurs nearly in all patients, to whom programmed hemodialysis (PHD) is applied. In majority of observations these disorders become compensated while administration of cholecalciferol (vitamin D3), calcitriol and etc. In 23 patients surgical treatment was performed to correct these disorders. Performance of subtotal parathyroidectomy (STPTHE) had promoted biochemical indexes normalization and the secondary HPTH clinical manifestations regression. The medicamental therapy nonefficacy, progressing osteoporosis, cutaneous itch, which is not connected the PHD procedure, raising of content of the ionized calcium and the alkaline phosphatase activity as well in the blood serum constitute indications for the STPTHE conduction.
Zavgorodniĭ
S N
SN
D000328:Adult; D005260:Female; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000150:complications* / Q000601:surgery*; D015918:Infusion Pumps, Implantable; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000379:methods*; D013727:Terminal Care
Operativnoe lechenie vtorichnogo giperparatireoza u patsientov s khronicheskoĭ pochechnoĭ nedostatochnost'iu v terminal'noĭ stadii, kotorym provodiat programmnyĭ gemodializ.